RISUG®: A potential candidate for the entry inhibitor group of antiretroviral drugs
- 31 August 2009
- journal article
- Published by Elsevier BV in Medical Hypotheses
- Vol. 73 (2), 150-152
- https://doi.org/10.1016/j.mehy.2009.02.033
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Critical role of Arg59 in the high-affinity gp120-binding region of CD4 for human immunodeficiency virus type 1 infectionVirology, 2007
- Effect of polyanion-resistance on HIV-1 infectionVirology, 2004
- Microbicidal male contraceptive—Risug induced morphostructural damage in E. coliColloids and Surfaces B: Biointerfaces, 2003
- Mandelic Acid Condensation Polymer: Novel Candidate Microbicide for Prevention of Human Immunodeficiency Virus and Herpes Simplex Virus EntryJournal of Virology, 2002
- HIV-1 cell entry and advances in viral entry inhibitor therapyJournal of Clinical Virology, 2002
- HIV-1 attachment: another lookTrends in Microbiology, 1999
- Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibodyNature, 1998